Wegovy (semaglutide) Weight Loss Injector 2.4 mg/0.75 mL
Wegovy is an injectable weight loss medication approved for adults with obesity or excess weight and weight-related conditions. It works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) to target areas of the brain that regulate appetite and food intake. The drug is designed for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment, or in patients with a BMI of 30 kg/m2 or greater 3 . Wegovy (semaglutide) was approved by the U.S. Food and Drug Administration (FDA) for chronic weight management, marking the first time since 2014 that federal health authorities had green-lighted a new weight loss drug. The medication is used in addition to a reduced calorie diet and increased physical activity 3 . Wegovy should be administered as an under-the-skin injection and the dosing must be increased gradually over 16 to 20 weeks to 2.4 mg once weekly to minimize gastrointestinal side e...